Douglas A Treco Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Douglas A Treco.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Douglas A Treco. Douglas A Treco is President and CEO in Ra Pharmaceuticals, Inc. ($RARX) and Director in CRISPR Therapeutics AG ($CRSP) and Director in Inozyme Pharma, Inc. ($INZY).
Latest Insider Trading Transactions of Douglas A Treco
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CRSP, INZY, RARX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 24 2020 | INZY | Inozyme Pharma, In ... | Treco Douglas A | Director | Option Exercise | A | 16.00 | 9,367 | 149,872 | 9,367 | |
| Jul 24 2020 | INZY | Inozyme Pharma, In ... | Treco Douglas A | Director | Option Exercise | A | 16.00 | 9,367 | 149,872 | 9,367 | |
| Jun 15 2020 | CRSP | CRISPR Therapeutic ... | Treco Douglas A | Director | Option Exercise | A | 59.70 | 30,000 | 1,791,000 | 30,000 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Option Exercise | D | 0.00 | 20,833 | 0 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Option Exercise | D | 21.00 | 311,000 | 6,531,000 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Option Exercise | D | 7.33 | 125,000 | 916,250 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Option Exercise | D | 16.64 | 225,000 | 3,744,000 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Option Exercise | D | 5.60 | 164,285 | 919,996 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Option Exercise | D | 2.87 | 241,460 | 692,990 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Option Exercise | D | 2.87 | 139,371 | 399,995 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Sell | D | 48.00 | 234,707 | 11,265,936 | 0 | 234.7 K to 0 (-100.00 %) |
| Feb 05 2019 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Option Exercise | M | 0.00 | 20,834 | 0 | 41,666 | |
| Feb 05 2019 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Option Exercise | A | 21.00 | 311,000 | 6,531,000 | 311,000 | |
| Feb 05 2019 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Payment of Exercise | F | 21.00 | 6,327 | 132,867 | 218,799 | 225.1 K to 218.8 K (-2.81 %) |
| Feb 05 2019 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Buy | M | 0.00 | 20,834 | 0 | 225,126 | 204.3 K to 225.1 K (+10.20 %) |
| Feb 05 2018 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Option Exercise | A | 0.00 | 62,500 | 0 | 62,500 | |
| Feb 05 2018 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Option Exercise | A | 7.33 | 125,000 | 916,250 | 125,000 |
Page: 1